Archive: 04/09/2017
Novartis eyes chief executive shake-up in 2018
Swiss pharmaceutical giant Novartis said Monday its chief executive for the past seven years, Joseph Jimenez, will step down in 2018, allowing chief medical officer Vasant Narasimhan to take the reins.
Sep 4, 2017
ICON8 trial reaffirms standard dosing in ovarian cancer chemo
European women with ovarian cancer can safely stick to the standard three-week dosing schedule for paclitaxel rather than boosting up to a weekly dose-dense regimen, according to results of the phase III ICON8 trial to be ...
Sep 4, 2017